| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |